866-997-4948(US-Canada Toll Free)

United States Serum Cancer Biomarkers Market Report 2016

Published By :

QYResearch

Published Date : Nov 2016

Category :

Cancer

No. of Pages : 105 Pages

Notes:
Sales, means the sales volume of Serum Cancer Biomarkers
Revenue, means the sales value of Serum Cancer Biomarkers

This report studies sales (consumption) of Serum Cancer Biomarkers in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Abbott Diagnostics
Agilent Technologies
Eli Lilly & Co.
EUSA Pharma
CytoCore, Inc.
GE Healthcare
Bruker Daltonics, Inc.
Biomarker Technologies, LLC
BioCurex, Inc.
Asuragen, Inc.
DiagnoCure, Inc.
Beckman Coulter, Inc.

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Serum Cancer Biomarkers in each application, can be divided into
Colorectal
Prostate
Lung
Breast
Ovarian

Table of Contents

United States Serum Cancer Biomarkers Market Report 2016
1 Serum Cancer Biomarkers Overview
1.1 Product Overview and Scope of Serum Cancer Biomarkers
1.2 Classification of Serum Cancer Biomarkers
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Serum Cancer Biomarkers
1.3.1 Colorectal
1.3.2 Prostate
1.3.3 Lung
1.3.4 Breast
1.3.5 Ovarian
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Serum Cancer Biomarkers (2011-2021)
1.4.1 United States Serum Cancer Biomarkers Sales and Growth Rate (2011-2021)
1.4.2 United States Serum Cancer Biomarkers Revenue and Growth Rate (2011-2021)

2 United States Serum Cancer Biomarkers Competition by Manufacturers
2.1 United States Serum Cancer Biomarkers Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Serum Cancer Biomarkers Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Serum Cancer Biomarkers Average Price by Manufactures (2015 and 2016)
2.4 Serum Cancer Biomarkers Market Competitive Situation and Trends
2.4.1 Serum Cancer Biomarkers Market Concentration Rate
2.4.2 Serum Cancer Biomarkers Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Serum Cancer Biomarkers Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Serum Cancer Biomarkers Sales and Market Share by Type (2011-2016)
3.2 United States Serum Cancer Biomarkers Revenue and Market Share by Type (2011-2016)
3.3 United States Serum Cancer Biomarkers Price by Type (2011-2016)
3.4 United States Serum Cancer Biomarkers Sales Growth Rate by Type (2011-2016)

4 United States Serum Cancer Biomarkers Sales (Volume) by Application (2011-2016)
4.1 United States Serum Cancer Biomarkers Sales and Market Share by Application (2011-2016)
4.2 United States Serum Cancer Biomarkers Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 United States Serum Cancer Biomarkers Manufacturers Profiles/Analysis
5.1 Abbott Diagnostics
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Serum Cancer Biomarkers Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Abbott Diagnostics Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Agilent Technologies
5.2.2 Serum Cancer Biomarkers Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Agilent Technologies Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Eli Lilly & Co.
5.3.2 Serum Cancer Biomarkers Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Eli Lilly & Co. Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 EUSA Pharma
5.4.2 Serum Cancer Biomarkers Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 EUSA Pharma Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 CytoCore, Inc.
5.5.2 Serum Cancer Biomarkers Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 CytoCore, Inc. Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 GE Healthcare
5.6.2 Serum Cancer Biomarkers Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 GE Healthcare Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Bruker Daltonics, Inc.
5.7.2 Serum Cancer Biomarkers Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Bruker Daltonics, Inc. Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Biomarker Technologies, LLC
5.8.2 Serum Cancer Biomarkers Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Biomarker Technologies, LLC Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 BioCurex, Inc.
5.9.2 Serum Cancer Biomarkers Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 BioCurex, Inc. Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Asuragen, Inc.
5.10.2 Serum Cancer Biomarkers Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Asuragen, Inc. Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 DiagnoCure, Inc.
5.12 Beckman Coulter, Inc.

6 Serum Cancer Biomarkers Manufacturing Cost Analysis
6.1 Serum Cancer Biomarkers Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Serum Cancer Biomarkers

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Serum Cancer Biomarkers Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Serum Cancer Biomarkers Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 United States Serum Cancer Biomarkers Market Forecast (2016-2021)
10.1 United States Serum Cancer Biomarkers Sales, Revenue Forecast (2016-2021)
10.2 United States Serum Cancer Biomarkers Sales Forecast by Type (2016-2021)
10.3 United States Serum Cancer Biomarkers Sales Forecast by Application (2016-2021)
10.4 Serum Cancer Biomarkers Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Serum Cancer Biomarkers
Table Classification of Serum Cancer Biomarkers
Figure United States Sales Market Share of Serum Cancer Biomarkers by Type in 2015
Table Application of Serum Cancer Biomarkers
Figure United States Sales Market Share of Serum Cancer Biomarkers by Application in 2015
Figure Colorectal Examples
Figure Prostate Examples
Figure Lung Examples
Figure Breast Examples
Figure Ovarian Examples
Figure United States Serum Cancer Biomarkers Sales and Growth Rate (2011-2021)
Figure United States Serum Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Table United States Serum Cancer Biomarkers Sales of Key Manufacturers (2015 and 2016)
Table United States Serum Cancer Biomarkers Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Serum Cancer Biomarkers Sales Share by Manufacturers
Figure 2016 Serum Cancer Biomarkers Sales Share by Manufacturers
Table United States Serum Cancer Biomarkers Revenue by Manufacturers (2015 and 2016)
Table United States Serum Cancer Biomarkers Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Serum Cancer Biomarkers Revenue Share by Manufacturers
Table 2016 United States Serum Cancer Biomarkers Revenue Share by Manufacturers
Table United States Market Serum Cancer Biomarkers Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Serum Cancer Biomarkers Average Price of Key Manufacturers in 2015
Figure Serum Cancer Biomarkers Market Share of Top 3 Manufacturers
Figure Serum Cancer Biomarkers Market Share of Top 5 Manufacturers
Table United States Serum Cancer Biomarkers Sales by Type (2011-2016)
Table United States Serum Cancer Biomarkers Sales Share by Type (2011-2016)
Figure United States Serum Cancer Biomarkers Sales Market Share by Type in 2015
Table United States Serum Cancer Biomarkers Revenue and Market Share by Type (2011-2016)
Table United States Serum Cancer Biomarkers Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Serum Cancer Biomarkers by Type (2011-2016)
Table United States Serum Cancer Biomarkers Price by Type (2011-2016)
Figure United States Serum Cancer Biomarkers Sales Growth Rate by Type (2011-2016)
Table United States Serum Cancer Biomarkers Sales by Application (2011-2016)
Table United States Serum Cancer Biomarkers Sales Market Share by Application (2011-2016)
Figure United States Serum Cancer Biomarkers Sales Market Share by Application in 2015
Table United States Serum Cancer Biomarkers Sales Growth Rate by Application (2011-2016)
Figure United States Serum Cancer Biomarkers Sales Growth Rate by Application (2011-2016)
Table Abbott Diagnostics Basic Information List
Table Abbott Diagnostics Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Diagnostics Serum Cancer Biomarkers Sales Market Share (2011-2016)
Table Agilent Technologies Basic Information List
Table Agilent Technologies Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies Serum Cancer Biomarkers Sales Market Share (2011-2016)
Table Eli Lilly & Co. Basic Information List
Table Eli Lilly & Co. Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly & Co. Serum Cancer Biomarkers Sales Market Share (2011-2016)
Table EUSA Pharma Basic Information List
Table EUSA Pharma Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table EUSA Pharma Serum Cancer Biomarkers Sales Market Share (2011-2016)
Table CytoCore, Inc. Basic Information List
Table CytoCore, Inc. Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table CytoCore, Inc. Serum Cancer Biomarkers Sales Market Share (2011-2016)
Table GE Healthcare Basic Information List
Table GE Healthcare Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table GE Healthcare Serum Cancer Biomarkers Sales Market Share (2011-2016)
Table Bruker Daltonics, Inc. Basic Information List
Table Bruker Daltonics, Inc. Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bruker Daltonics, Inc. Serum Cancer Biomarkers Sales Market Share (2011-2016)
Table Biomarker Technologies, LLC Basic Information List
Table Biomarker Technologies, LLC Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biomarker Technologies, LLC Serum Cancer Biomarkers Sales Market Share (2011-2016)
Table BioCurex, Inc. Basic Information List
Table BioCurex, Inc. Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioCurex, Inc. Serum Cancer Biomarkers Sales Market Share (2011-2016)
Table Asuragen, Inc. Basic Information List
Table Asuragen, Inc. Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Asuragen, Inc. Serum Cancer Biomarkers Sales Market Share (2011-2016)
Table DiagnoCure, Inc. Basic Information List
Table DiagnoCure, Inc. Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table DiagnoCure, Inc. Serum Cancer Biomarkers Sales Market Share (2011-2016)
Table Beckman Coulter, Inc. Basic Information List
Table Beckman Coulter, Inc. Serum Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Beckman Coulter, Inc. Serum Cancer Biomarkers Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Serum Cancer Biomarkers
Figure Manufacturing Process Analysis of Serum Cancer Biomarkers
Figure Serum Cancer Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Serum Cancer Biomarkers Major Manufacturers in 2015
Table Major Buyers of Serum Cancer Biomarkers
Table Distributors/Traders List
Figure United States Serum Cancer Biomarkers Production and Growth Rate Forecast (2016-2021)
Figure United States Serum Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Table United States Serum Cancer Biomarkers Production Forecast by Type (2016-2021)
Table United States Serum Cancer Biomarkers Consumption Forecast by Application (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *